AI in Biotechnology Market worth $22,716.5 million by 2035 with 18.5% CAGR | MarketsandMarkets (TM).

The global AI in Biotechnology Market, valued at US$3.51000 million in 2024, stood at US$4,156.9 million in 2025 and is projected to ...

We applied swim flume-mediated exercise during zebrafish caudal fin regeneration to explore mechanical loading impacts on a robust model of organ regeneration. Exercise initiated during but not after ...

By procedure type, the preimplantation genetic testing market is divided by procedure type into preimplantation genetic ...

Simply put, Illumina tends to have better profitability ratios compared to its peers. For instance, Illumina has a 68.38% ...

Illumina’s third quarter results reflected stable year-over-year revenue and a notable beat on Wall Street’s profit expectations, with positive market reaction following the report. Management ...

(Bloomberg) --China announced it will remove retaliatory tariffs on some US farm products and lift export controls on an array of American firms, after Washington halved its fentanyl-related levies on ...

Revenue: $1.08 billion, roughly flat year-over-year, exceeded guidance range. Non-GAAP Operating Margin: 24.5%, expanded by 190 basis points year-over-year. Non-GAAP Diluted EPS: $1.34, grew $0.20 ...

NovaSeq X Transition Progress A key focus for Illumina continues to be the transition to its NovaSeq X platform, which is progressing according to plan. The company reported over 50 NovaSeq X ...

Background: Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide, primarily due to delayed diagnosis. There is an urgent need for sensitive, noninvasive ...

Oct 21 (Reuters) - Biotech company 10x Genomics (TXG.O), opens new tab filed two lawsuits against rival Illumina (ILMN.O), opens new tab in Delaware federal court on ...